Endocardial Mapping With the CoreMap EP Mapping System

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 245 participants.

Also called NCT06529978

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 245 participants (planned count) (from the registry)
Sponsor
CoreMap Inc. (from the registry)
Registry
  • NCT NCT06529978
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Czechia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06529978. Non-randomized; no masking; primary purpose treatment. Start 2024-07-25 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endocardial Mapping With the CoreMap EP Mapping System
Acronym
INvENI
Condition
Persistent Atrial Fibrillation
Intervention (Device)
CoreMap EP Mapping System Mapping
Intervention (Device)
CoreMap EP Mapping System Map-Guided Ablation
Lead sponsor
CoreMap Inc. (class: industry)

Record details

Record id
cardio:ct-nct06529978
Content hash
6226b5dc8c4bdfa375bfda2dc586826edb9485eddd0081a2c16ad7c09c7222d8